Image

Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme

Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme

Recruiting
20-40 years
All
Phase N/A

Powered by AI

Overview

The aim of this study is to evaluate the feasibility and acceptability of a new community-based programme designed to tackle loneliness for young and working-age adults. The programme focuses on encouraging social interactions and connections through offering community initiatives and activities, online spaces for interaction, and free or low-cost social events for young adults. Further aims of this study are to determine the cost-effectiveness of the programme.

Description

Loneliness is associated with adverse mental and physical health outcomes. Most interventions are aimed at older adults even though young adults, including those of working-age, have been identified as being at-risk for persistent loneliness. This study aims to formatively evaluate the feasibility and acceptability of a community-based social interaction intervention. Therefore, the main objectives of this study are to:

  1. Assess the feasibility and acceptability of the community-based intervention.
  2. To determine the costs and effects related to the community-based intervention using quantitative feasibility study data and qualitative interviews with study participants.

In this mixed-methods two-arm randomised feasibility study with qualitative evaluation, participants will be randomly allocated to the community-based intervention over 12 weeks or to the wait-list control group. The intervention consists of weekly community social activities with the aim of reducing feelings of loneliness. Participants in the wait-list control group can continue any standard care or support they were receiving e.g. use of GP or mental health services. For both groups, online self-report assessments will take place at baseline (time 0, t0), 12-week follow-up (end of the intervention period; time 1, t1) and 6-weeks post intervention (18-weeks after baseline, time 2, t2). For the intervention group, an additional qualitative interview will be taken at the final timepoint (time 3, t3; 6 weeks post-intervention).

Eligibility

Inclusion Criteria:

  • Age 20-40
  • Reside in London
  • Reports that they are some of the time or often lonely in response to a single questionnaire item ("How often do you feel lonely?)
  • No prior interaction with the community-based intervention we are investigating
  • Able to communicate in English sufficiently well to engage in qualitative interviews and complete the outcome measures and questionnaires.
  • Available and willing to participate in the study for 18 weeks

Exclusion Criteria:

  • Age < 20 or age >40.
  • Resides outside of London.
  • Does not report frequent levels of loneliness ("hardly ever or never" in response to single questionnaire item).
  • Previously attended any event or is an existing member of the community-based programme that is forming the intervention arm.
  • Unable to communicate even with communication support.
  • Planned unavailability for >3 weeks during intervention and follow up periods.
  • Participating in another research project related to loneliness.
  • Reports current severe unstable health problems (mental or physical) or is deemed overburdened with respect to participating in research.

Study details
    Loneliness

NCT06805136

Queen Mary University of London

16 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.